key: cord-0916845-1jb7zipx
authors: PRAKASH, P.; MEENA, R.; STANLEY, A.B.R.A.H.A.M.; SWETHA, S.U.N.K.A.R.; GOVINDARAJU, K.; DURGASRUTHI, P.U.L.L.Y.; ANTONY, V.S.A.M.R.O.T.
title: EVIDENCE-BASED traditional Siddha formulations for prophylaxis and management of respiratory symptoms in COVID-19 pandemic- a review
date: 2021-06-07
journal: Biocatal Agric Biotechnol
DOI: 10.1016/j.bcab.2021.102056
sha: 237893862d6b64781313bb667a20dd523e5d66cc
doc_id: 916845
cord_uid: 1jb7zipx

The recent outbreak of COVID-19 is attributed to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This viral disease is rapidly spreading across the globe, including India. The mainstay in managing the disease is supportive care, nutrition, and preventing further progression in the absence of proven antiviral drugs. Currently two vaccines Covishield and Covaxin are administered in India. Long-term plans of developing most reliable mRNA-based vaccines are also underway for the future method of prophylaxis. The Siddha system of medicine’s holistic approach emphasizes lifestyle modification, prophylactic interventions, and dietary management to boost the host immunity and treatment with herbal medicines and higher-order medicines as the case may be. In this review, a brief outline of the disease COVID-19, Coronavirus, evidence-based traditional Siddha interventions for respiratory ailments, immune boosters highlighting the relevant published research on individual herbs are dealt, which pave way for further research on drug repurposing for COVID-19. Historical evidence on the prevention and treatment of infections in Siddha classics is studied. Web search in databases such as Embase, Biomed Central Articles, Pub med, NLM, Web of Science CrossRef, Google scholar, AYUSH research portal, google search engine related to antiviral properties of herbs used in the preparation of Siddha drugs was also carried out.

Coronaviruses are single-strand RNA viruses causing enzootic diseases (Schoeman and Fielding, 2019) , categorized into four subgroups as alpha, Beta, Gamma, and Delta. Human In late 2019, there were several outbreaks of novel Pneumonia in a Seafood market in Wuhan, Hubei province, China, caused by a novel beta coronavirus-Wuhan coronavirus sharing 79.5% of the genome similarity with SARS-CoV, which caused 2002 -2003 and renamed as SARS-CoV-2 by International committee on taxonomy of viruses (Firas et al, 2020) . Later by January 30th, 2020, WHO declared the COVID-19 as the sixth major international public health emergency. Human coronaviruses are transmitted from animals, either rodents or bats, and this particular SARS-CoV-2 has reportedly been spread from pangolins in China (Cyranoski, 2020) . These viruses are enveloped with a lipid layer containing spikes-like structure resembling crown structure and hence the name Coronavirus J o u r n a l P r e -p r o o f (Crown in Latin -Corona) (Figure 1 ). These spikes include several unique diversified surfaces receptor-binding domain (RBD), which bind with the angiotensin-converting enzyme-2 (ACE-2) receptor present in lungs, heart, gastrointestinal tract, and kidneys which form (Ksiazek et al, 2003) the viral admission into the host cell (Firas et al, 2020) .

After the viral entry, the SARS-CoV-2 fix to the ACE-2 receptors in the type II pneumocytes found in the lungs. This attachment triggers a cascade of inflammatory processes in the lower respiratory system. Further, it activates the spike protein through a process of type 2 transmembrane protease TMPRSS-2 which further leads to the cleavage of ACE 2 ( Figure 2 ) (Kuba et al, 2005; Glowacka et al; 2011; Heurich et al, 2014) . This route of cellular infection triggers the immune response of the host and activates the inflammatory cascade through the initiation of antigen-presenting cells (APC), which performs two significant functions viz., exposing the antigen to CD 4 + -Th1 cells and liberating IL-12 to stimulate the T helper cell further and followed by stimulation of CD 8 + -Tk cells. This, in turn, targets any cells with the extraneous antigen, followed by B-cells' stimulation to yield antigen-specific antibodies by activating Th1 cells (Firas et al, 2020) . The immunocompromised host becomes more susceptible to this virus and increases the mortality rate. WHO reported the transmission rate of this virus i.e., R0, to be between 1.4 and 2.5 and the incubation period after the viral entry into the host organism ranging from 2 to 14 days, making them more vulnerable to transmit through respiratory droplets than airborne transmission. Asymptomatic transmission made them to isolate the infected patients and cure them effectively. Also, age-related risks and pre-existing diseases increase the fatality rate (Firas et al, 2020 ).

In the current scenario, the management of novel coronavirus infection is focused on supportive care and testing the prevailing anti-corona viral drugs efficacy. Antiviral drugs used during the past epidemics of beta coronavirus, such as interferon, darunavir, ribavirin, and lopinavir, are currently being evaluated for their potential through in vitro tests (Chu et al, 2004) . Initially, Adenosine analog, Remdesivir, which was earlier used against RNA viruses like SARS, MERS, and Ebola treatment, was used to treat the SARS-CoV-2 infection (Sheahan et al, 2017) . Also, Camostat mesylate, Chloroquine, and Hydroxy Chloroquine are The antimalarial drug hydroxychloroquine has been authorized by The Indian Council of 

The Siddha medical system is a comprehensive traditional medicinal system with its origin in India's southern part. It has now started spreading its roots across the globe. The immuneboosting food and medicines are available in plenty in the Siddha system of medicine. water following oleation should be practiced for a healthy living (Anaivarai and Anandhan, 2005 ).

Siddha's treatment is personalized based on the naadi ( 

There are various preventive measures and lifestyle habits mentioned in the Siddha system of medicine that effectively prevent respiratory infections. Consuming Vitex negundo leaves grounded and mixed with Piper nigrum three times a day will bring down the phlegmatic fever (Pillai, 2006) . Turmeric water, Alum water serve as traditional hand sanitizers. Turmeric water is an effective antiviral. The practice of spraying turmeric water is in practice in many Indian villages as a tradition. Curcuma longa is one of the ingredients in many Siddha formulations administered for cough and cold. Turmeric powder, when taken with hot milk, brings out the phlegm in the throat. Also, inhaling the smoke from burning turmeric relieves nasal congestion, reduces headache and cold (Pillai, 1948) . Neem leaf fumigation will act as an environmental sanitizer.

The strategy of administering immunomodulators for prevention in a risk group, decoctions and herbal preparations in asymptomatic and mild cases, and higher-order medicines in severely infected cases, if followed, will give a promising cure. The taste, potency, and actions of the herbs used in respiratory illness are described in Table1. 

pandemic:

The herbs mentioned and the formulations mentioned are not proved as a treatment for COVID-19 disease. List of Siddha medications towards COVID-19 are discussed in Table 2 . 

Any drug with its therapeutic effect has its own side effects when the preparation and prescription are misappropriated. Though there prevails a common thought that AYUSH treatment is safe, it is not so always. The safety of a drug relies on the purification of raw drugs, preparation of the drug as per the prescribed protocol, dose, duration and period of administration, adjuvant used, etc. Toxicity studies have been conducted for numerous Siddha formulations to establish the safety concern. Velmurugan et al (2017) 

Vitex negundo is used in decoction preparation and steam inhalation indicated for respiratory illness. Previously in a study conducted by Sangeetha Kothandan and Rajarajan Swaminathan et al (2014) J o u r n a l P r e -p r o o f Lin et al (2003) have reported that Terminalia chebula exhibits antiviral activity against HSV-1 which is probably intermediated through inhibition of initial entry of HSV-1 virus and free virus particle inactivation. In another study, it was reported that the Chebulagic acid and

Punicalagin isolated from the herb chebulic myroblan was liable for the antiviral effect against HSV-1 and the possible mechanism of drug action also was dealt (2011). Terminalia chebula has shown antiviral activity against the influenza A virus (Badmaev and Nowakowski, 2000) .

Camphecene, isolated from Dryobalanops aromatica showed the activity against the viruses, influenza viruses A and B in direct hemagglutinin inhibition tests, and trials carried out with mice infected by the influenza virus (Zarubaev et al, 2015) .

Apart from herbs, The exact mechanism of compound Siddha formulations against SARS-CoV -2 is not established. Kadukkai is one of the major ingredients of the drug Triphala chooranam.

Chebulagic acid and punicalagin isolated from Terminalia chebula inactivate the free respiratory viral particles and prevent early entry including attachment and penetration phases (Lin et al, 2013) . Triphala chooranam which is used for prophylaxis and treatment of infections significantly thwarts elevation of IL-4 levels. It also modifies the decreased IL-2 and IFN-γ levels. The immunosuppressive activity of Triphala is attributed to its inhibitory action on complement system, humoral immunity, cell mediated immunity and mitogen-J o u r n a l P r e -p r o o f

induced T-lymphocyte proliferation. Research studies shows that the aqueous and alcoholic extracts of the Terminalia chebula, Terminaia bellerica, Emblica officinalis enhances the macrophage activation due to their free radical scavenging activity and the ability to neutralize reactive oxygen species Belapurkar et al., 2014) . Nagam (Zinc) is one of the constituents of Siddha higher order medicines. Zinc is a potent immunostimulant and antiinflammatory agent. In parpam (ashes), zinc is converted into nano size. The antiinflammatory mechanisms assumed by zinc oxide nanoparticles are inhibition of the NF-κβ pathway and inhibition of mast cell degranulation, inhibition of inducible nitric oxide synthase (iNOS) enzyme expression, inhibition of pro-inflammatory cytokines release and myeloperoxidase inhibition (Kim et al., 2015; Cortese-krott et al., 2014; Klostedudfen and Hauptmann, 1996; Navaei-nigjeh et al., 2018) .

The Siddha system of medicine has hoarded many experiences in handling endemic/epidemic 

Global Trends Pharm Sci.,10, (Kshirsagar and Rao, 2021) S. G. Kshirsagar, R. V. Rao.

Medicina (Kaunas). 57 (3) 

Pohlmann TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein

Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings

Feng, I. Trantcheva, et al Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Chennai: Department of Indian Medicine and Homoeopathy

Leite Evaluation of Siddha Samadhi Yoga for anxiety and depression symptoms: A preliminary study

Booklet on Common Yoga Protocol. Ministry of AYUSH, Government of India

Kapa Sura Kudineer"-a Siddha formulary prediction for swine flu

Anti-Inflammatory, Antipyretic and Antibacterial Study of Kabasura Kudineer Choornam

DOI

Protection of epithelial cells against influenza A virus by plant derived biological response modifier Ledretan-96

Sokolova et al Broad range of inhibiting action of novel camphor-based compound with antihemagglutinin activity against influenza viruses in vitro and in vivo

Kar et al, 2020)

Ayurvedic preventive and curative protocol for Covid 19 -a proposal

Bafna PS, Patil SD. Physicochemical characterisation and antiinflammatory activity of Ayurvedic herbo-metallic Tamra Bhasma in acute and chronic models of inflammation

Nano-formulation of herbo-mineral alternative medicine from linga chenduram and evaluation of antiviral efficacy

Inhibitory effect of silver nanomaterials on transmissible virus-induced host cell infections

Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo

Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry

Immunomodulatory effects of triphala and its individual constituents: a review

Zinc Oxide Nanoparticles Suppress LPS Induced NF-B Activation by Inducing A20 , a Negative Regulator of NF-KB

Zinc regulates iNOS-derived nitric oxide formation in endothelial cells

Influence of Heat Shock Protein 70 and Metallothionein Induction by on the Release of Inflammatory Mediators in a Porcine Model of Recurrent Endotoxemia

Molecular and Biochemical Evidences for Beneficial Effects of Zinc Oxide Nanoparticles in Modulation of Chlorpyrifos Toxicity in Human Lymphocytes

J o u r n a l P r e -p r o o f HIGHLIGHTS  Historical evidence on the prevention and treatment of infections in Siddha classics was studied  Web search in databases related to antiviral properties of herbs used in the preparation of Siddha drugs was also carried out  Siddha compound formulations could serve as an alternative method for COVID-19 treatment and prevention in a high-risk population and asymptomatic COVID-19 patients along with the mainstream treatment protocol J o u r n a l P r e -p r o o f

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: J o u r n a l P r e -p r o o f